Company profile for Cyclica

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cyclica is a Toronto-based, globally recognized biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's proprietary structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenom...
Cyclica is a Toronto-based, globally recognized biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's proprietary structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
207 Queens Quay West, Suite 420 Toronto, Ontario, M5J 1A7
Telephone
Telephone
(416) 304-9201
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Recursion to acquire two Canadian drug discovery startups
Recursion to acquire two Canadian drug discovery startups

09 May 2023

// Gwendolyn Wu BIOPHARMADIVE

https://www.biopharmadive.com/news/recursion-cyclica-valence-AI-drug-discovery/649686/

Gwendolyn Wu BIOPHARMADIVE
09 May 2023

https://www.prnewswire.com/news-releases/cyclica-teams-up-with-uruguay-national-research-agency-anii-to-enhance-scientific-innovation-301770660.html

PR NEWSWIRE
14 Mar 2023

http://www.koreabiomed.com/news/articleView.html?idxno=14304

KOREABIOMED
02 Aug 2022

https://www.businesswire.com/news/home/20220323005554/en

BUSINESSWIRE
23 Mar 2022

https://www.businesswire.com/news/home/20220209005345/en

BUSINESSWIRE
09 Feb 2022

https://www.businesswire.com/news/home/20220201005518/en

BUSINESSWIRE
01 Feb 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty